Carcinogenicity of ethylmethanesulfonate.
D000008:Abdominal Neoplasms / Q000139:chemically induced; D000230:Adenocarcinoma / Q000139:chemically induced; D000236:Adenoma / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced; D004921:Erythropoietin / Q000097:blood; D004952:Esters / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D007274:Injections, Intraperitoneal; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D008479:Mediastinal Neoplasms / Q000139:chemically induced; D008697:Methane / Q000008:administration & dosage / Q000009:adverse effects*; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009392:Nephrectomy; D010911:Pituitary Neoplasms / Q000139:chemically induced; D051381:Rats; D012509:Sarcoma / Q000139:chemically induced; D012737:Sex Factors; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D013964:Thyroid Neoplasms / Q000139:chemically induced; D013997:Time Factors
D002273:Carcinogens; D004952:Esters; D013451:Sulfonic Acids; D004921:Erythropoietin; D008697:Methane